GlassScriptPhysician profile
Hamid Shidban
NPI 1942246111
$1,933.76
in general payments reported to CMS, 2019-2025
15 companies · $54.99 in 2025
The $54.99 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $125 · 2022: $121 · 2023: $230 · 2024: $883 · 2025: $54.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,168.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veloxis Pharmaceuticals, INC. | $418.96 | 2019-2023 | Envarsus |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $343.70 | 2023-2024 | |
| Inari Medical, INC. | $214.13 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Otsuka America Pharmaceutical, INC. | $165.31 | 2019 | |
| Conmed Corporation | $164.79 | 2024 | Visiclear |
| Medtronic, INC. | $144.48 | 2024 | Signia |
| Takeda Pharmaceuticals U.S.A., INC. | $142.94 | 2022-2023 | Livtencity |
| Merck Sharp & Dohme LLC | $99.94 | 2024 | Prevymis |
| Baxter Healthcare | $86.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.16 | 2024 | |
| Amgen INC. | $28.70 | 2025 | Krystexxa |
| Novartis Pharmaceuticals Corporation | $26.98 | 2024 | |
| Akebia Therapeutics INC | $26.29 | 2025 | Vafseo |
| Calliditas Therapeutics US INC. | $24.13 | 2024 | |
| Lemaitre Vascular, INC. | $14.83 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamid Shidban listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.